Seropharmacological Study on Osteogenic Effects of Post-absorption Ingredients of an Osteoprotective Herbal Formula

Overview

Journal Chin J Integr Med

Date 2016 Jun 15

PMID 27299462

Citations 2

Authors

Wing-Sum Siu

Chun-Hay Ko

Hing-Lok Wong

Si Gao

Wai-Ting Shum

Clara Bik-San Lau

Lung-Kim Hung

Ping-Chung Leung

Affiliations

Soon will be listed here.

Abstract

Objective: To further investigate the {ptin vitro} effects of an osteoprotective herbal formula "ELP" (Herba Epimedii, Fructus Ligustri Lucidi and Fructus Psoraleae) using seropharmacological approach.

Methods: Rats were fed with ELP or its individual component herbs for 2 days. The serum containing the postabsorbed ingredients of the herbal items were collected for cell culture using UMR106 cell, RAW264.7 cell and mesenchymal stem cell (MSC) isolated from the bone marrow of the rats. The effects of the herbal-containing serum on cell toxicity were detected by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; bromodeoxyuridine assay was conducted to measure the cell proliferation of UMR106 cell and MSC; cell activity was measured using colorimetric method, and mRNA expression of runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteopontin (OPN) of UMR106 and MSC as well as matrix metalloproteinase 9 (MMP-9), tartrate-resistant acid phosphatase (TRAP) and cathepsin K of RAW264.7 were analyzed using real-time reverse-transcription polymerase chain reaction.

Results: ELP and its component serum exhibited no cytotoxic effects on the cells. The ELP-containing serum increased the proliferation of UMR106 cell and MSC by 25.7% and 14.4 %, respectively and the alkaline phosphatase activity of MSC was increased by 42.6%. On the contrary, it inhibited the RAW264.7 cell differentiation by 29.2 %. ELP serum upregulated the Runx2 expression of UMR and MSC by 1.18 fold and 1.27 fold, respectively. It also upregulated ALP and OPN expression in MSC by 1.69- and 2.12-fold, respectively. On the other hand, ELP serum down-regulated MMP-9 and cathepsin K expression of RAW264.7 cell by 0.46- and 0.36-fold, respectively.

Conclusions: The serum of the animals fed with ELP contains active ingredients which are effective in promoting osteogenesis and inhibiting osteoclastogenesis.

Citing Articles

Therapeutic potential of Chinese medicinal herbs stimulating osteogenic differentiation of bone marrow-derived mesenchymal stem cells in osteoporosis.

Wang H, Shan K, Li Y, Wu S, Zhou C, Tao S Front Pharmacol. 2024; 15:1423555.

PMID: 39144620 PMC: 11322149. DOI: 10.3389/fphar.2024.1423555.

Green tea protects against hippocampal neuronal apoptosis in diabetic encephalopathy by inhibiting JNK/MLCK signaling.

Xu Y, Liu S, Zhu L, Dai L, Qian W, Zhang J Mol Med Rep. 2021; 24(2).

PMID: 34132368 PMC: 8223107. DOI: 10.3892/mmr.2021.12214.

References

Sutton E, Riche D . Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. Ann Pharmacother. 2012; 46(7-8):1000-9. DOI: 10.1345/aph.1Q543. View

Mok S, Chen W, Lai W, Leung P, Wang X, Yao X . Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol. 2010; 159(4):939-49. PMC: 2829219. DOI: 10.1111/j.1476-5381.2009.00593.x. View

Chen Q, Yang L, Zhang G, Wang F . Bioactivity-guided Isolation of antiosteoporotic compounds from Ligustrum lucidum. Phytother Res. 2012; 27(7):973-9. DOI: 10.1002/ptr.4820. View

Deal C, Draper M . Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety. Womens Health (Lond). 2009; 2(2):199-210. DOI: 10.2217/17455057.2.2.199. View

Ming L, Chen K, Xian C . Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol. 2012; 228(3):513-21. DOI: 10.1002/jcp.24158. View

Christenson E, Jiang X, Kagan R, Schnatz P . Osteoporosis management in post-menopausal women. Minerva Ginecol. 2012; 64(3):181-94. View

Iwama H, Amagaya S, Ogihara Y . Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method. J Ethnopharmacol. 1987; 21(1):45-53. DOI: 10.1016/0378-8741(87)90093-6. View

Cheung W, Tse M, Ngan T, Lin J, Lee W, Poon W . Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Clin Toxicol (Phila). 2009; 47(7):683-5. DOI: 10.1080/15563650903059136. View

Abrahamsen B, Eiken P, Eastell R . Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2008; 24(6):1095-102. DOI: 10.1359/jbmr.081247. View

10.

Chen W, Mok S, Wang X, Lai K, Lai W, Luk H . Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Br J Nutr. 2010; 105(2):180-9. DOI: 10.1017/S0007114510003247. View

11.

Zhang J, Yang L, Meng G, Yuan Z, Fan J, Li D . Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators. PLoS One. 2013; 8(2):e57251. PMC: 3577746. DOI: 10.1371/journal.pone.0057251. View

12.

Huang J, Yuan L, Wang X, Zhang T, Wang K . Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci. 2007; 81(10):832-40. DOI: 10.1016/j.lfs.2007.07.015. View

13.

Neviaser A, Lane J, Lenart B, Edobor-Osula F, Lorich D . Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008; 22(5):346-50. DOI: 10.1097/BOT.0b013e318172841c. View

14.

Migliorati C, Siegel M, Elting L . Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol. 2006; 7(6):508-14. DOI: 10.1016/S1470-2045(06)70726-4. View

15.

Zhao J, Ohba S, Komiyama Y, Shinkai M, Chung U, Nagamune T . Icariin: a potential osteoinductive compound for bone tissue engineering. Tissue Eng Part A. 2009; 16(1):233-43. DOI: 10.1089/ten.TEA.2009.0165. View

16.

Xie F, Wu C, Lai W, Yang X, Cheung P, Yao X . The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med. 2005; 2(3):353-61. PMC: 1193542. DOI: 10.1093/ecam/neh101. View

17.

Chen K, Ge B, Liu X, Ma P, Lu M, Bai M . Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie. 2007; 62(5):388-91. View

18.

Vieillard M, Maes J, Penel G, Facon T, Magro L, Bonneterre J . Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy. Joint Bone Spine. 2007; 75(1):34-40. DOI: 10.1016/j.jbspin.2007.05.003. View

19.

Li G, Zhang X, Zhang J, Chan C, Yew D, He M . Ethanol extract of Fructus Ligustri Lucidi promotes osteogenesis of mesenchymal stem cells. Phytother Res. 2009; 24(4):571-6. DOI: 10.1002/ptr.2987. View

20.

Ko C, Siu W, Wong H, Gao S, Shum W, Lau C . In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis. Evid Based Complement Alternat Med. 2012; 2012:203732. PMC: 3488414. DOI: 10.1155/2012/203732. View